MedTrace Logo

Analysis of Revascularisation in Ischemic Stroke With EmboTrap

NCT02190552 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2019-03-11

Study results available
· View outcomes & findings →

Summary

A.R.I.S.E. is a post approval observational study using standard care. The purpose of this study is to collect information about the ability of the EmboTrap device to remove blood clots from the brain, and the associated performance characteristics and clinical outcomes. No formal hypothesis testing is needed as no comparisons are planned within the study. Instead, estimates of each population parameter of interest for all primary and secondary endpoints will be provided using appropriate confidence intervals.

Conditions

Interventions

DEVICE

EmboTrap® Revascularization Device

Sponsors & Collaborators

  • Neuravi Limited

    lead INDUSTRY

Principal Investigators

  • Dr. Tommy Andersson · Karolinska Institutet

  • Prof. Dr. Heinrich Mattle · Insel Gruppe AG, University Hospital Bern

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-05-31
Completion
2018-01-31

Countries

  • Denmark
  • Germany
  • Ireland
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02190552 on ClinicalTrials.gov